About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The aim of our group is to investigate the use of medicines and evaluate its benefit/risk relationship in usual clinical practice. Our group coordinates the Catalan centre of the Spanish System of Pharmacovigilance. Research activities on pharmacology and pharmacoepidemiology are coupled with undergraduate teaching at the Autonomous University of Barcelona Medical School, training of specialists in clinical pharmacology, and continuous education of health professionals on therapeutics.
The group is a Special Group of Research recognized by AGAUR GenCat. It is a partner of “The European Consortium “EU PE&PV Network” (European Pharmacoepidemiology and Pharmacovigilance Network)” and it is part of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). It gives institutional support to the Clinical Research Ethical Committee of the University hospital Vall d’Hebron (UHVH), the Drug and Pharmacotherapeutic Committee of the UHVH, and also to the Drug and Pharmacotherapeutic Committee of the Institut Català de la Salut.
PMID: 35134393 Journal: JOURNAL OF AFFECTIVE DISORDERS Year: 2022 Reference: J Affect Disord. 2022 Apr 15;303:131-137. doi: 10.1016/j.jad.2022.02.001. Epub 2022 Feb 5. Impact factor: 4.839 Publication type: Paper in international publication Authors: van Dijk, L; Camacho-Arteaga, L F; Gardarsdottir, H; Ibanez, L; Souverein, P C; Ballarin, E; Sabate, M; Vidal, X; Hek, K et al. DOI: 10.1016/j.jad.2022.02.001
PMID: 35762253 Journal: EXPERT OPINION ON BIOLOGICAL THERAPY Year: 2022 Reference: Expert Opin Biol Ther. 2022 Jul;22(7):831-842. doi: 10.1080/14712598.2022.2093637. Epub 2022 Jul 4. Impact factor: 4.388 Publication type: Paper in international publication Authors: Antonio, Vallano; Merce, Obach; Antonia, Agusti; Carolina, Iglesias-Lopez et al. DOI: 10.1080/14712598.2022.2093637
PMID: 35795713 Journal: EClinicalMedicine Year: 2022 Reference: EClinicalMedicine. 2022 Jul 1;50:101529. doi: 10.1016/j.eclinm.2022.101529. eCollection 2022 Aug. Impact factor: 0 Publication type: Paper in international publication Authors: Castano, Luis; Borobia, Alberto M; Castillo de la Osa, Maria; Gonzalez-Perez, Maria; Garcia-Perez, Javier; Bertran, Maria Jesus; Campins, Magdalena; Lora, David; Perez-Olmeda, Mayte; Alcami, Jose et al. DOI: 10.1016/j.eclinm.2022.101529
PMID: 35404224 Journal: Journal of Clinical Sleep Medicine Year: 2022 Reference: J Clin Sleep Med. 2022 Jul 1;18(7):1857-1864. doi: 10.5664/jcsm.10016. Impact factor: 4.062 Publication type: Paper in international publication Authors: Sampol, Julia, Saez, Maria, Marti, Sergi, Pallero, Mercedes, Barrecheguren, Miriam, Ferrer, Jaume, Sampol, Gabriel, Vimes Fortis, Alba, Guillen Del Castillo, Alfredo, et al. DOI: 10.5664/jcsm.10016
PMID: 33483292 Journal: CYTOTHERAPY Year: 2021 Reference: Cytotherapy. 2021 Mar;23(3):261-274. doi: 10.1016/j.jcyt.2020.11.008. Epub 2021 Jan 19. Impact factor: Publication type: Paper in international publication Authors: Agusti, Antonia; Iglesias-Lopez, Carolina; Obach, Merce; Vallano, Antonio et al. DOI: 10.1016/j.jcyt.2020.11.008
PMID: 33431183 Journal: MEDICINA CLINICA Year: 2021 Reference: Med Clin (Barc). 2021 May 21;156(10):509-514. doi: 10.1016/j.medcli.2020.10.015. Epub 2021 Jan 9. Impact factor: Publication type: Paper in national publication Authors: Bosch Ferrer, Montserrat; Filippi-Arriaga, Francesca; Riera-Arnau, Judit; Rodriguez-Acevedo, Breogan et al. DOI: 10.1016/j.medcli.2020.10.015
PMID: 32941394 Journal: TRANSPLANTATION Year: 2021 Reference: Transplantation. 2021 Jan 1;105(1):138-150. doi: 10.1097/TP.0000000000003460. Impact factor: Publication type: Paper in international publication Authors: Alonso-Martinez, Carla; Anton, Andres; Berastegui, Cristina; Castells, Lluis; Del-Rio-Gutierrez, Jose-Manuel; Domenech, Laura; Garcia-Garcia, Sonia; Garcia-Ortega, Patricia; Gomez-Ganda, Laura; Gorgas-Torner, Maria-Queralt et al. DOI: 10.1097/TP.0000000000003460
PMID: 34830495 Journal: Journal of Clinical Medicine Year: 2021 Reference: J Clin Med. 2021 Nov 9;10(22). pii: jcm10225213. doi: 10.3390/jcm10225213. Impact factor: 4.242 Publication type: Paper in international publication Authors: Sempere, Abiu, Salvador, Fernando, Monforte, Arnau, Sampol, Julia, Espinosa-Pereiro, Juan, Miarons, Marta, Bosch-Nicolau, Pau, Guillen-Del-Castillo, Alfredo, Aznar, Maria Luisa, Campos-Varela, Isabel et al. DOI: 10.3390/jcm10225213
The results show the need for continuous monitoring of patients to detect and manage possible adverse effects occurring months and years after treatment.
The creation of hybrid digital-human interaction spaces between avatars and people offers new opportunities for personalized medicine
The study by physician Emilie Anderssen seeks to optimize the medicalization of people living in nursing homes.
